Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment outcomes of alternating chemoradiotherapy for nasopharyngeal carcinoma: a single-center safety and efficacy study

Published:2023-05 Issue:3 Volume:89 Page:440-446
ISSN:1808-8694
Container-title:Brazilian Journal of Otorhinolaryngology
language:en
Short-container-title:Brazilian Journal of Otorhinolaryngology

Author:

Ohara Kenzo^ORCID,Takahara Miki^ORCID,Kumai Takumi^ORCID,Yamashina Masaaki^ORCID,Kishibe Kan^ORCID,Katada Akihiro^ORCID,Hayashi Tatsuya^ORCID

Publisher

Elsevier BV

Subject

Otorhinolaryngology

Reference26 articles.

1. Meta-analysis on induction chemotherapy in locally advanced nasopharyngeal carcinoma;Mané;Oncologist.,2021

2. Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials;Chen;Clin Cancer Res,2018

3. NCCN guidelines insights: head and neck cancers, Version 1.2018;Colevas;J Natl Compr Canc Netw,2018

4. Treatment of childhood nasopharyngeal carcinoma with induction chemotherapy and concurrent chemoradiotherapy: results of the Children’s Oncology Group ARAR0331 Study;Rodriguez-Galindo;J Clin Oncol.,2019

5. The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials;Yu;Onco Targets Ther.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble CD27 as a predictive biomarker for intra‐tumoral CD70/CD27 interaction in nasopharyngeal carcinoma;Cancer Science;2024-01-27

2. Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer;Frontiers in Medicine;2023-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3